ALPN
Alpine Immune Sciences Inc
ALPN
ALPN
Delisted
ALPN was delisted on the 17th of May, 2024.
23 hedge funds and large institutions have $27.4M invested in Alpine Immune Sciences Inc in 2018 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 7 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
57% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 7
Holders
23
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$453K | |
| 2 | +$261K | |
| 3 | +$25.1K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$6.39K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$6K |
Top Sellers
| 1 | -$506K | |
| 2 | -$398K | |
| 3 | -$99.2K | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$83.6K |
| 5 |
Millennium Management
New York
|
-$68K |